Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ACTAIR 300 IR COMPRIMIDOS SUBLINGUALES - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/ACTAIR 300 IR COMPRIMIDOS SUBLINGUALES

Approved

STANDARD

ACTAIR 300 IR COMPRIMIDOS SUBLINGUALES

Stallergenes🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Nov 18, 2021
Approval ID: f3a30d742ab67f61
Company: Stallergenes
Type: Standard

Approval Details

Approval Id: f3a30d742ab67f61
Drug Cima Aemps Name: ACTAIR 300 IR COMPRIMIDOS SUBLINGUALES
Register Number: 86405
Holder Company Name: Stallergenes
Marketing Company Name: Stallergenes Iberica S.A.
Holder Company Detail Path: /organization/stallergenes
Authorization Date: 2021-11-18
Dosage Form: COMPRIMIDO SUBLINGUAL
Dose: 300 IR
Route Of Administration: VÍA SUBLINGUAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Stallergenes
Company Detail Path: /organization/stallergenes

Company Information

Pharmaceutical Company Name: STALLERGENES
Country Name: France
City Name: antony,ile de france,country_fr
Address: 6 RUE ALEXIS DE TOCQUEVILLE

Active Ingredients

EXTRACTO ALERGENICO DE DERMATOPHAGOIDES FARINAE

150 IR

EXTRACTO ALERGENICO DE DERMATOPHAGOIDES PTERONYSSINUS

150 IR

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Nov 18, 2021

Approval ID

f3a30d742ab67f61

Type

Standard

Back to CIMA-AEMPS Approvals